Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
CHF-247,631.11
% of Total Estimate Gain
-3.33%

Aspiriant Risk-Managed Equity Allocation Fund's Roche Holding AG Holding Summary

As of 2025-03-31, Aspiriant Trust held - shares of Roche Holding AG(XSWX:ROG), totaling N/A. This investment constitutes 0% of their stock portfolio, and Aspiriant Trust now holds 0% of the outstanding Roche Holding AG(XSWX:ROG) stock.

The initial trade took place in 2019Q4. And since then Aspiriant Risk-Managed Equity Allocation Fund has made 6 purchases of XSWX:ROG, at an average price of CHF316.86, for a total of 23,486.00 shares. In addition, there have been 7 sales at an average price of CHF306.32 for 23,486.00 shares. Based on historical transaction data and XSWX:ROG's current price of CHF258.50, Aspiriant Risk-Managed Equity Allocation Fund's estimated gain on his XSWX:ROG holdings is CHF-247,631.11, reflecting a -3.33% gain to date.

Aspiriant Risk-Managed Equity Allocation Fund XSWX:ROG (CHF258.50) Holding Chart

Aspiriant Risk-Managed Equity Allocation Fund XSWX:ROG (CHF258.50) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price CHF-/Share
Shares Sold 0 Average Price CHF-/Share
Current Price CHF0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1